We are excited to share a momentous breakthrough in Alzheimer’s research that brings new hope for individuals suffering from Alzheimer’s disease and their families. The drug lecanemab has shown promising results in clinical trials, potentially slowing the progression of Alzheimer’s disease.
What is Lecanemab?
Lecanemab is an antibody treatment designed to target and remove amyloid plaques from the brain — the protein deposits that are a hallmark of Alzheimer’s disease. Clinical trials have shown that lecanemab can slow cognitive decline in people with early-stage Alzheimer’s by approximately 27%.
What This Means for People Living with Dementia
While lecanemab is not a cure for Alzheimer’s, the results represent a significant step forward. For the first time, we have a treatment that appears to meaningfully slow the progression of the disease, rather than simply managing symptoms.
Homecare and Dementia Support in Dublin
While we await further developments in Alzheimer’s treatment, homecare continues to play a vital role in supporting people living with dementia to remain in their own homes for as long as possible. At HomeCarer Trusted Independent Living, our specialist dementia care services are provided by trained Healthcare Assistants who understand the unique challenges of caring for someone with Alzheimer’s or other forms of dementia.
Contact us on 01 406 4285 or care@homecarer.ie to discuss dementia homecare in Dublin.